Please login to the form below

Hanover Health launches the Mackay Programme

New programme for communicators looking to breakthrough in their careers.

Hanover Health has today launched The Mackay Programme to offer experienced professionals the opportunity to switch careers by joining an award-winning healthcare communications consultancy that helps to change the lives of millions for the better.

The programme, open to non-healthcare agency professionals and experienced communicators working in the wider healthcare sector, will provide comprehensive training and development to help propel successful candidates into a global healthcare communications career.

The selected candidates will join the Hanover Health team, who provide smart thinking, refreshing storytelling and breakthrough solutions to a wide range of global clients including: pharmaceutical and medical technology companies, healthcare service providers, charities, professional and public-sector bodies.

The programme will include:

· Fundamental training on our company, our services, our healthcare offer and how the business is run

· Industry-recognised training opportunities and participation in our Hanover Academy training programme

· Investment and budget to spend on CPD or professional qualifications to further career development

· Attendance at industry conferences and events

· The ability to draw on our network of experts in the sector (the Hanover Group is part of AVENIR GLOBAL, a global network of comms and public affairs consultancies)

· Opportunities to work with colleagues in our Brussels, Dublin and Middle East offices

· Immersion within an entrepreneurial environment

· Hanover Group benefits and additional perks

Successful candidates will be placed at levels ranging from Consultant up to Associate Director.

This opportunity is suited to those with a passion for communications and a drive to join a fast-paced, breakthrough industry.

Applicants must be able to demonstrate strong communications skills and an interest in the sector but no prior experience in healthcare is necessary. Applications close: Friday 10th April 2020. Shortlisted candidates will be invited to interview at the Hanover office in London.

The Mackay programme is dedicated to one of Hanover’s founders, Gregor Mackay, who died in 2005 eight weeks after being diagnosed with a rare form of cancer. Mackay personified an “uncommon sense” approach and took particular interest in the development of people and teams.

Andrew Harrison, Managing Director of Hanover Health, said:

“At Hanover Health, we recognise that the best innovation and creative problem-solving requires diverse thinking.

This is why we’re looking for the brightest minds across communications, public affairs and healthcare, to help bring fresh thinking, bold ideas and broad experience into the industry. The sector is constantly evolving, and this opportunity offers a different cohort of talent the chance to be part of this change, working with clients who are on the cusp of the latest research and technology to improve lives for the better.

It is only fitting to name it after Gregor Mackay, a man who personified the breakthrough approach, and who recognised the transformational power of great communications.”

For more information and to apply please visit www.hanovercomms.com or contact recruitment@hanovercomms.com.

-ends-

NOTES TO EDITORS

  1. Hanover Health’s team provides product and corporate communications, market access, policy and public affairs at an international and local level from its offices in London, Brussels, Dublin, Dubai and Abu Dhabi. Hanover Health is part of the wider Hanover Group. Hanover Group is part of the AVENIR GLOBAL group of companies. More information can be found at www.hanovercomms.com.

2. Hanover Health works with over half of the world’s top 20 pharmaceutical companies, as well as health technology businesses, trade associations, charities and healthcare providers. The fast-growing practice has been an important part of the Hanover Group’s overall expansion – a 25% average annual growth rate for the last five years.

3. Hanover Health won three prestigious industry awards in 2019: PharmaTimes International Team of the Year, EMEA Sabre Medical Technology and PRWeek Awards: Issues and Reputation Management.

4. Hanover Health is chaired by Sarah Matthew, co-founder of Virgo Health and one of the most influential figures in healthcare communications.

11th February 2020

Share

Tags

Company Details

Hanover Communications

+44 (0)20 7400 4480

Contact Website

Address:
Riverside House
Southwark Bridge House
London
SE1 9HA
United Kingdom

Latest content on this profile

What's next for the 'indispensable' health system?
No one is remotely indispensable” – those of the words many of us have heard these past few weeks. As Boris Johnson and the previously incumbent Cabinet are now considering their next moves, where does that leave health policy at one of the most volatile points in recent history? We were set for a bumper few months of hotly anticipated announcements, including the 10-Year Cancer  Plan response, the Women’s Health Strategy, and the implementation plan for the Life Sciences Vision, amongst many others. But what will happen as the forthcoming leadership contest dominates the column inches? How will the Civil Service and NHS stand up to the challenges it faces without certainty of who is steering the ship? We will explore some of the possibilities of what will happen next, and most importantly, how we in communications can support the health system at such a critical time post-pandemic. To find out, read the latest blog on the PM Hub, penned by Hanover Health's Senior Account Director Ursula Ritz.
Hanover Communications
How can the UK be a catalyst for change in women’s health? 
Women’s health has once again been thrust to the fore, with almost daily stories on hormone replacement therapy (HRT) supply shortages in the UK providing us with a stark reminder of the challenges women are facing in this country every day. The good news is, the UK Government is making a genuine and concerted effort to tackle women’s health issues, having set out its Vision for women’s health in December, and a full Strategy due to be published imminently. We have a real opportunity to change women’s experience of healthcare for the better, but we cannot afford to get this wrong. In her latest blog, Hanover’s Georgia Hunt explores how the upcoming Women’s Health Strategy should address the concerns of women today and improve the lives of the women of tomorrow.
Hanover Communications
Innovative contracting at the top of the market access agenda
Value-based contracting (VBC) is firmly on the market access agenda across Europe and there are converging views on what is needed in this space.  Pharma and biotech, patients, payers, regulators and HTA agencies gathered at the World Evidence, Pricing and Access Congress in March to discuss challenges and potential solutions. Hanover hosted a discussion about experiences of VBC and where changes are needed. We explored whether a global archetype approach could support in-country negotiating agreements.   In their latest blog, Hanover Health’s Emma Eatwell and Josie Godfrey explore what the future for VBC might look like.
Hanover Communications
The future of nanomedicine regulation
With the EU’s upcoming revision of the general pharmaceutical legislation, the bloc has the chance to provide long-awaited clarity around the future of nanomedicine. And just as important, it will give the EU a chance to lead on a conversation around the needed regulatory framework for nanomedicines as other countries -including the US- currently struggle with this. In their latest blog, Hanover Brussels Alicia Rojo Santos and Pilar Serrano explores why the sector expecting to set off following the success of the Pfizer and Moderna SARS-CoV-2 vaccines is more important than ever.
Hanover Communications
Getting it Right First Time: Building a Value-Based Contract Strategy
In their latest blog, Hanover Brussels Emma Eatwell and Josie Godfrey will explore how companies can efficiently and effectively increase the chances of securing value-based contracts that work for all.
Hanover Communications
The role of pharma in breaking through the backlog
As health systems emerge from the pandemic, and attention turns to the backlog of patients waiting for treatment, how can the pharmaceutical industry position itself as part of the solution? In his latest blog, Hanover Health’s Alexander Davies looks to answer the following questions – big pharma was there for the world when it needed vaccines in record-breaking time, can it find the innovations that we need now to clear through the queue of people waiting for treatment? Can it partner with health systems to speed up access, improve patient outcomes and reduce the burden on healthcare professionals? And, if it did so, what are the opportunities for its reputation?
Hanover Communications